Literature DB >> 30838235

Eye of the Tiger Sign and Very Late Onset in Dentatorubral-Pallidoluysian Atrophy.

Joana Morgado1, Sofia Reimão2,3, Miguel Coelho4,3, Mário M Rosa4,3,5, Joaquim J Ferreira4,3,5, Leonor Correia Guedes4,3.   

Abstract

Entities:  

Keywords:  DRPLA; eye of the tiger sign; late onset

Year:  2015        PMID： 30838235      PMCID： PMC6353528          DOI： 10.1002/mdc3.12179

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  15 in total

1.  Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.

Authors:  T Müller; G Amoiridis; W Kuhn; H Przuntek
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

2.  Neurological picture. Distinctive MRI abnormalities in a man with dentatorubral-pallidoluysian atrophy.

Authors:  Mark Simpson; Andrew Smith; Hugh Kent; Richard Roxburgh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-02-22       Impact factor: 10.154

3.  Eye-of-the-tiger-sign in a 48 year healthy adult.

Authors:  Simon J A van den Bogaard; Mark C Kruit; Eve M Dumas; Raymund A C Roos
Journal:  J Neurol Sci       Date:  2013-10-09       Impact factor: 3.181

4.  Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty.

Authors:  A Macerollo; R Perry; M Stamelou; A Batla; A A Mazumder; M E Adams; K P Bhatia
Journal:  Eur J Neurol       Date:  2014-02       Impact factor: 6.089

5.  Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length.

Authors:  Arika Hasegawa; Takeshi Ikeuchi; Ryoko Koike; Nae Matsubara; Miyuki Tsuchiya; Hiroaki Nozaki; Atsushi Homma; Jiro Idezuka; Masatoyo Nishizawa; Osamu Onodera
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

6.  β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.

Authors:  Susan J Hayflick; Michael C Kruer; Allison Gregory; Tobias B Haack; Manju A Kurian; Henry H Houlden; James Anderson; Nathalie Boddaert; Lynn Sanford; Sami I Harik; Vasuki H Dandu; Nardo Nardocci; Giovanna Zorzi; Todd Dunaway; Mark Tarnopolsky; Steven Skinner; Kenton R Holden; Steven Frucht; Era Hanspal; Connie Schrander-Stumpel; Cyril Mignot; Delphine Héron; Dawn E Saunders; Margaret Kaminska; Jean-Pierre Lin; Karine Lascelles; Stephan M Cuno; Esther Meyer; Barbara Garavaglia; Kailash Bhatia; Rajith de Silva; Sarah Crisp; Peter Lunt; Martyn Carey; John Hardy; Thomas Meitinger; Holger Prokisch; Penelope Hogarth
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

7.  Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study.

Authors:  Paula Coutinho; Luis Ruano; José L Loureiro; Vitor T Cruz; José Barros; Assunção Tuna; Clara Barbot; João Guimarães; Isabel Alonso; Isabel Silveira; Jorge Sequeiros; José Marques Neves; Pedro Serrano; M Carolina Silva
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

8.  Sporadic ataxias in Japan--a population-based epidemiological study.

Authors:  Shoji Tsuji; Osamu Onodera; Jun Goto; Masatoyo Nishizawa
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 9.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations.

Authors:  Susanne A Schneider; John Hardy; Kailash P Bhatia
Journal:  Mov Disord       Date:  2011-10-26       Impact factor: 10.338

10.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682
View more
  1 in total

Review 1.  Pallidal degenerations and related disorders: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-08-07       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.